您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    医保支付制度改革对药品使用的影响

    摘要

    医保支付制度改革对药品市场影响很大。进入医保药品目录的产品占国内药品市场的60%左右,医保已是药品市场的最大买家。确立医保支付制度的目标是改革的核心问题,有效地控制药价虚高、过度医疗、药占比等突出问题是医改面临的重大课题。将改革目标锁定在医保支付方式上,确定“总额预付,按病种付费,医保支付标准”三项制度,从原来的后付制转为预付制。实际上就是一种包干制。在这种付费方式下,医院的管理,医生的诊疗,药品采购、药价的形式,企业的营销,政府的监管都将随之发生转变。

    <<
    >>

    Abstract

    The health insurance payment system reform has a great impact on the drug market.The drugs covered by the health insurance drug catalogue accounts for about 60% of the domestic drug market scale.The health insurance has become the biggest buyer in the drug market.Establishing the goals of the health insurance payment system correctly is central to the reform.Effectively keeping some outstanding issues under control,such as unreasonably high prices of drugs,excessive medical treatment and drug ratios,is an important subject the reform faces.Focus the goal of the reform on the payment methods of the health insurance,establish three systems of “Global Budget,Diseases Related to Groups,Health Insurance Payment Standard”,and shift from the previous post payment to advance payment.Actually,it's a system of payment partly in kind and partly in cash.With this payment method,the management of hospitals,doctors' diagnosis and treatment,the procurement of drugs,the categorization of drug prices,pharmaceutical enterprises' marketing,and the government's supervision will also change accordingly.

    <<
    >>
    作者简介
    赖诗卿:国家卫生健康委员会体改司监察专员、客座教授
    <<
    >>
    相关报告